Another study found that CCL18 could promote the invasiveness and metastasis of urothelial carcinoma through activation of the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway (168). The gene discussed is MTOR; the disease is urothelial carcinoma.